Pharma-Bio Serv (PBSV) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Pharma-Bio Serv (PBSV) over the last 14 years, with Q4 2025 value amounting to $199929.0.
- Pharma-Bio Serv's Accumulated Depreciation & Amortization fell 6962.71% to $199929.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $199929.0, marking a year-over-year decrease of 6962.71%. This contributed to the annual value of $199929.0 for FY2025, which is 6962.71% down from last year.
- Latest data reveals that Pharma-Bio Serv reported Accumulated Depreciation & Amortization of $199929.0 as of Q4 2025, which was down 6962.71% from $658249.0 recorded in Q4 2024.
- Over the past 5 years, Pharma-Bio Serv's Accumulated Depreciation & Amortization peaked at $658249.0 during Q4 2024, and registered a low of $199929.0 during Q4 2025.
- For the 5-year period, Pharma-Bio Serv's Accumulated Depreciation & Amortization averaged around $523732.0, with its median value being $587089.0 (2022).
- Per our database at Business Quant, Pharma-Bio Serv's Accumulated Depreciation & Amortization soared by 904.65% in 2022 and then tumbled by 6962.71% in 2025.
- Pharma-Bio Serv's Accumulated Depreciation & Amortization (Quarter) stood at $538384.0 in 2021, then rose by 9.05% to $587089.0 in 2022, then grew by 8.16% to $635009.0 in 2023, then grew by 3.66% to $658249.0 in 2024, then crashed by 69.63% to $199929.0 in 2025.
- Its last three reported values are $199929.0 in Q4 2025, $658249.0 for Q4 2024, and $635009.0 during Q4 2023.